Pdt Partners, LLC Denali Therapeutics Inc. Transaction History

Pdt Partners, LLC

$1.01 Billion
Q1 2024

A detailed history of Pdt Partners, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 158,384 shares of DNLI stock, worth $3.68 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

158,384

Previous 32,900 381.41%

Holding current value

$3.68 Million

Previous $706,000 360.34%

% of portfolio

0.32%

Previous 0.08%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$15.83 - $23.35 $1.99 Million - $2.93 Million	125,484 Added 381.41%	158,384 $3.25 Million
Q4 2023 Feb 14, 2024	BUY	$16.2 - $23.18 $532,980 - $762,622	32,900 New	32,900 $706,000
Q3 2022 Nov 14, 2022	SELL	$25.97 - $38.53 $149,405 - $221,663	-5,753 Reduced 15.83%	30,588 $939,000
Q2 2022 Aug 15, 2022	BUY	$20.88 - $35.19 $386,092 - $650,698	18,491 Added 103.59%	36,341 $1.07 Million
Q1 2022 May 16, 2022	BUY	$29.0 - $47.27 $517,650 - $843,769	17,850 New	17,850 $574,000

Q4 2021 Feb 14, 2022	SELL	$42.59 - $55.02 $647,368 - $836,304	-15,200 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$48.48 - $78.23 $507,391 - $818,755	10,466 Added 221.08%	15,200 $767,000
Q2 2021 Aug 16, 2021	SELL	$50.3 - $78.44 $881,809 - $1.38 Million	-17,531 Reduced 78.74%	4,734 $371,000
Q1 2021 May 17, 2021	BUY	$53.8 - $81.53 $244,897 - $371,124	4,552 Added 25.7%	22,265 $1.27 Million
Q4 2020 Feb 16, 2021	SELL	$36.89 - $93.56 $2 Million - $5.07 Million	-54,224 Reduced 75.38%	17,713 $1.48 Million
Q3 2020 Nov 16, 2020	BUY	$23.13 - $38.84 $313,110 - $525,777	13,537 Added 23.18%	71,937 $2.58 Million
Q2 2020 Aug 14, 2020	SELL	$16.01 - $28.82 $292,983 - $527,406	-18,300 Reduced 23.86%	58,400 $1.41 Million
Q1 2020 May 15, 2020	BUY	$14.2 - $27.98 $550,917 - $1.09 Million	38,797 Added 102.36%	76,700 $1.34 Million
Q4 2019 Feb 14, 2020	SELL	$14.4 - $19.99 $20,289 - $28,165	-1,409 Reduced 3.58%	37,903 $660,000
Q3 2019 Nov 14, 2019	BUY	$15.32 - $21.92 $430,369 - $615,776	28,092 Added 250.37%	39,312 $602,000
Q2 2019 Aug 14, 2019	BUY	$18.5 - $28.14 $207,570 - $315,730	11,220 New	11,220 $233,000

Others Institutions Holding DNLI

# of Institutions

217

Shares Held

115M

Call Options Held

142K

Put Options Held

90.3K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.12B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account